| Physical activity and exercise in lung cancer care: will promises be fulfilled? A Avancini, G Sartori, A Gkountakos, M Casali, I Trestini, D Tregnago, ... The oncologist 25 (3), e555-e569, 2020 | 141 | 2020 |
| PTEN in lung cancer: dealing with the problem, building on new knowledge and turning the game around A Gkountakos, G Sartori, I Falcone, G Piro, L Ciuffreda, C Carbone, ... Cancers 11 (8), 1141, 2019 | 92 | 2019 |
| Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex A Gkountakos, S Pilotto, A Mafficini, C Vicentini, M Simbolo, M Milella, ... Carcinogenesis 39 (8), 971-980, 2018 | 65 | 2018 |
| MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy S Pilotto, A Gkountakos, L Carbognin, A Scarpa, G Tortora, E Bria Annals of translational medicine 5 (1), 2017 | 55 | 2017 |
| Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system G Grizzi, M Caccese, A Gkountakos, L Carbognin, G Tortora, E Bria, ... Expert Review of Molecular Diagnostics 17 (12), 1055-1069, 2017 | 31 | 2017 |
| Muscle derangement and alteration of the nutritional machinery in NSCLC I Trestini, A Gkountakos, L Carbognin, A Avancini, M Lanza, A Molfino, ... Critical reviews in oncology/hematology 141, 43-53, 2019 | 18 | 2019 |
| Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR … A Gkountakos, G Centonze, E Vita, L Belluomini, M Milella, E Bria, ... Biomedicines 10 (2), 277, 2022 | 11 | 2022 |
| Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients A Gkountakos, P Delfino, RT Lawlor, A Scarpa, V Corbo, E Bria Therapeutic advances in medical oncology 13, 17588359211006947, 2021 | 10 | 2021 |
| An overview of circulating biomarkers in neuroendocrine neoplasms: a clinical guide M Bevere, F Masetto, ME Carazzolo, A Bettega, A Gkountakos, A Scarpa, ... Diagnostics 13 (17), 2820, 2023 | 9 | 2023 |
| PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis A Rossi, VD Noia, A Gkountakos, E D’Argento, G Sartori, E Vita, ... Immunotherapy 11 (10), 921-930, 2019 | 8 | 2019 |
| An insight on functioning pancreatic neuroendocrine neoplasms M Bevere, A Gkountakos, FM Martelli, A Scarpa, C Luchini, M Simbolo Biomedicines 11 (2), 303, 2023 | 7 | 2023 |
| Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas A Gkountakos, A Mafficini, E Lou, G Malleo, R Salvia, M Calicchia, ... Human pathology 128, 124-133, 2022 | 7 | 2022 |
| Undifferentiated sarcomatoid carcinoma of the pancreas: from histology and molecular pathology to precision oncology A Gkountakos, M Simbolo, E Bariani, A Scarpa, C Luchini International Journal of Molecular Sciences 23 (3), 1283, 2022 | 6 | 2022 |
| Extrahepatic distal cholangiocarcinoma vs. Pancreatic ductal adenocarcinoma: histology and molecular profiling for differential diagnosis and treatment A Gkountakos, FM Martelli, N Silvestris, M Bevere, M De Bellis, L Alaimo, ... Cancers 15 (5), 1454, 2023 | 5 | 2023 |
| Clinical and genomic characterization of pancreatic ductal adenocarcinoma with signet-ring/poorly cohesive cells M Simbolo, N Silvestris, G Malleo, A Mafficini, L Maggino, A Cocomazzi, ... Modern Pathology 36 (9), 100251, 2023 | 4 | 2023 |
| Molecular bases for combinatorial treatment strategies in patients with KRAS mutant lung adenocarcinoma and squamous cell lung carcinoma C Lazzari, A Verlicchi, A Gkountakos, S Pilotto, M Santarpia, I Chaib, ... Pulmonary Therapy 2, 1-18, 2016 | 3 | 2016 |
| Fusion genes in pancreatic tumors A Gkountakos, AD Singhi, CB Westphalen, A Scarpa, C Luchini Trends in Cancer, 2024 | 2 | 2024 |
| Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications M Simbolo, G Centonze, L Giudice, F Grillo, P Maisonneuve, ... Cancers 14 (19), 4653, 2022 | 2 | 2022 |
| Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models A Gkountakos, S Pilotto, M Simbolo, C Vicentini, A Mafficini, ... Annals of Oncology 29, viii665, 2018 | 2 | 2018 |
| 63P Molecular bases for combinatorial treatment strategies in KRAS mutant (KRASm) lung adenocarcinoma (LAC) C Lazzari, N Karachaliou, A Verlicchi, I Chaib, S Marin, A Gkountakos, ... Journal of Thoracic Oncology 11 (4), S82, 2016 | 2 | 2016 |
